Vestcor Inc Sells 7,543 Shares of Maximus, Inc. (NYSE:MMS)

Vestcor Inc lessened its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 43.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,654 shares of the health services provider's stock after selling 7,543 shares during the period. Vestcor Inc's holdings in Maximus were worth $721,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of MMS. Avantax Advisory Services Inc. boosted its holdings in shares of Maximus by 4.8% during the 4th quarter. Avantax Advisory Services Inc. now owns 19,097 shares of the health services provider's stock worth $1,426,000 after buying an additional 869 shares during the period. Farther Finance Advisors LLC boosted its holdings in Maximus by 109.2% during the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after acquiring an additional 428 shares during the period. Inspire Advisors LLC grew its position in shares of Maximus by 3.1% in the fourth quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after purchasing an additional 258 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Maximus by 19.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,413 shares of the health services provider's stock worth $1,151,000 after purchasing an additional 2,464 shares during the period. Finally, Ruffer LLP acquired a new position in shares of Maximus during the 4th quarter worth about $10,266,000. Institutional investors own 97.21% of the company's stock.

Remove Ads

Maximus Stock Performance

Maximus stock traded up $0.88 during trading hours on Monday, hitting $67.99. The stock had a trading volume of 623,762 shares, compared to its average volume of 479,922. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a market cap of $3.85 billion, a PE ratio of 14.62 and a beta of 0.71. The company has a 50-day moving average of $71.83 and a two-hundred day moving average of $79.13. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. Maximus's payout ratio is currently 25.81%.

Analysts Set New Price Targets

MMS has been the topic of several research analyst reports. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a report on Thursday, January 2nd.

Insider Transactions at Maximus

In other news, CEO Bruce Caswell bought 3,500 shares of the business's stock in a transaction dated Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the purchase, the chief executive officer now owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.